Related Experiment Video
Updated: Jan 10, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
Small-Volume Dissolution Testing of Pediatric Mini-Tablets Using Miniaturized USP Apparatuses: Regulatory and
Stefanie Broocks1, Melanie Gebhardt1, Sandra Klein2
1Department of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, 3 Felix Hausdorff Street, 17489, Greifswald, Germany.
Abstract:
Mini-tablets (MTs) have gained increasing importance as age-appropriate dosage forms, particularly for pediatric patients, due to their ease of swallowing and flexible dosing capabilities. Despite their growing use, regulatory guidance and standardized quality control (QC) methods specifically adapted to MTs, especially extended-release (ER) formulations, are still lacking. This study investigates the suitability of two miniaturized dissolution apparatuses for evaluating ER MTs: a Mini-Paddle system, which is a geometrically downscaled version of the compendial Paddle (USP 2) apparatus, and a small-volume Reciprocating-Holder (USP 7) apparatus. Two commercially available pediatric ER MT drug products containing melatonin and sodium valproate were tested individually and in deliberately manipulated batches to assess the methods' sensitivity and discriminatory power. The Mini-Paddle apparatus reliably quantified drug release from melatonin MTs but encountered limitations with low-dose sodium valproate MTs, requiring the pooling of multiple units, which masked individual variability. Conversely, the small-volume Reciprocating-Holder enabled sensitive, single-unit testing for both products, effectively detecting batch-to-batch differences despite very low drug loads. Neither apparatus currently holds official compendial status, emphasizing the urgent need for regulatory recognition and standardized methodologies. This study highlights the critical need for sensitive, miniaturized dissolution methods tailored to the unique challenges of MTs to ensure consistent quality, safety, and efficacy, particularly in vulnerable populations. Future work should focus on harmonizing and validating miniaturized dissolution systems to support QC and regulatory acceptance of MT formulations.
Insights
Mini-tablets (MTs) require specialized dissolution testing. A small-volume Reciprocating-Holder apparatus demonstrated superior sensitivity for evaluating extended-release (ER) mini-tablets compared to a Mini-Paddle system.
Area of Science:
- Pharmaceutical Technology
- Drug Delivery Systems
- Analytical Chemistry
Background:
- Mini-tablets (MTs) are crucial pediatric dosage forms, but lack standardized quality control (QC) methods, especially for extended-release (ER) formulations.
- Existing QC methods may not adequately assess the performance of miniaturized drug delivery systems.
Purpose of the Study:
- To evaluate two miniaturized dissolution apparatuses (Mini-Paddle and small-volume Reciprocating-Holder) for assessing ER MTs.
- To determine the sensitivity and discriminatory power of these systems for pediatric drug products.
Main Methods:
- Tested melatonin and sodium valproate ER MTs using Mini-Paddle (USP 2) and small-volume Reciprocating-Holder (USP 7) apparatuses.
- Assessed drug release from individual and manipulated batches to evaluate method performance.
Main Results:
- The Reciprocating-Holder apparatus provided sensitive, single-unit testing for both drug products, detecting batch variations.
- The Mini-Paddle apparatus showed limitations with low-dose formulations, masking individual variability due to unit pooling.
Conclusions:
- The small-volume Reciprocating-Holder is a promising tool for QC of ER MTs, offering superior sensitivity.
- Standardized, miniaturized dissolution methods are urgently needed for regulatory acceptance and quality assurance of MTs.
Related Concept Videos
In Vitro Drug Dissolution: Compendial Testing Models I
In Vitro Drug Dissolution: Compendial Testing Models II
In Vitro Drug Dissolution: Alternative Methods
Drug Dissolution: Requirements and Profile Comparison
Factors Affecting Dissolution: Particle Size and Effective Surface Area
In Vitro Drug Release Testing: Overview, Development and Validation

